IRIS
COLACI, Michele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.028
AS - Asia 1.456
EU - Europa 1.229
SA - Sud America 333
AF - Africa 146
AN - Antartide 1
Totale 7.193
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.893
SG - Singapore 864
IE - Irlanda 488
CN - Cina 453
IT - Italia 320
BR - Brasile 310
CA - Canada 114
RU - Federazione Russa 112
CI - Costa d'Avorio 107
UA - Ucraina 80
DE - Germania 45
GB - Regno Unito 33
FR - Francia 32
IN - India 32
FI - Finlandia 19
KR - Corea 19
AT - Austria 16
CH - Svizzera 16
SE - Svezia 15
NG - Nigeria 14
SN - Senegal 12
IQ - Iraq 11
AR - Argentina 10
BD - Bangladesh 10
CZ - Repubblica Ceca 10
NL - Olanda 10
UZ - Uzbekistan 10
VN - Vietnam 9
GR - Grecia 8
LB - Libano 8
MX - Messico 8
TR - Turchia 8
MA - Marocco 6
DO - Repubblica Dominicana 5
EC - Ecuador 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
PK - Pakistan 4
PL - Polonia 4
BE - Belgio 3
BG - Bulgaria 3
HK - Hong Kong 3
ID - Indonesia 3
RO - Romania 3
ZA - Sudafrica 3
ES - Italia 2
GT - Guatemala 2
JM - Giamaica 2
KZ - Kazakistan 2
LK - Sri Lanka 2
PY - Paraguay 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
JP - Giappone 1
LU - Lussemburgo 1
MK - Macedonia 1
NI - Nicaragua 1
OM - Oman 1
PS - Palestinian Territory 1
VE - Venezuela 1
Totale 7.193
Salva come PNG Salva come JPEG
Città #
Santa Clara 833
Chandler 736
Dublin 488
Singapore 467
Chicago 192
Houston 169
Boardman 165
Lawrence 126
Cambridge 122
Andover 120
Nanjing 115
New York 111
Abidjan 107
Ashburn 107
Jacksonville 83
Toronto 77
Des Moines 75
Catania 58
Beijing 41
Wilmington 40
Civitanova Marche 35
Hefei 35
The Dalles 35
Columbus 34
Ottawa 31
Saint Petersburg 29
Shenyang 27
Jiaxing 25
Nanchang 25
Hebei 23
Bremen 22
Falls Church 22
Los Angeles 21
Ann Arbor 20
São Paulo 20
Seoul 19
Milan 18
Council Bluffs 17
Kochi 17
Tianjin 15
Abuja 14
Changsha 13
Palermo 13
Belo Horizonte 12
Dakar 12
Rio de Janeiro 11
Jesi 10
Washington 10
Brno 9
Kunming 9
Norwalk 9
Seattle 9
Jinan 8
Cesa 7
Guangzhou 7
Paterno 7
Turku 7
Baghdad 6
Edinburgh 6
Giarre 6
Helsinki 6
Lappeenranta 6
Munich 6
Nuremberg 6
Reggio Emilia 6
Rome 6
San Francisco 6
Vienna 6
Atlanta 5
Brooklyn 5
Changchun 5
Curitiba 5
Den Haag 5
Messina 5
Turin 5
Brasília 4
Campinas 4
Latina 4
Pennisi 4
Princeton 4
Pune 4
Riyadh 4
Stockholm 4
Taubaté 4
Brussels 3
Campo Largo 3
Chennai 3
Contagem 3
Dallas 3
Dhaka 3
Dong Ket 3
Fuzhou 3
Hong Kong 3
Istanbul 3
Jakarta 3
Lahore 3
Lanzhou 3
Manchester 3
Mauá 3
Mexico City 3
Totale 5.074
Salva come PNG Salva come JPEG
Nome #
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study 148
Endocrine disorders associated with hepatitis C virus chronic infection 134
Clinical, serological and radiological features of a prospective cohort of Interstitial Pneumonia with Autoimmune Features (IPAF) patients 88
Heart involvement and systemic sclerosis 78
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 77
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 76
ADHERENCE TO THERAPY IN RHEUMATIC PATIENTS TREATED WITH SUBCUTANEOUS BIOLOGICS 74
Patients with Interstitial Lung Disease Secondary to Autoimmune Diseases: How to Recognize Them? 74
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection 72
Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature 72
COVID-19-related retinal microvasculopathy and systemic implications in patients with severe disease: results from the Methuselah study 70
Associations between Systemic Sclerosis and Thyroid Diseases 70
Nailfold videocapillaroscopy alterations in dermatomyositis and systemic sclerosis: Toward identification of a specific pattern 70
COMPARISON BETWEEN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS AND INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURES: A PROSPECTIVE COHORT 69
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 69
Neutrophil-to-Lymphocyte Ratio (NLR) Is a Promising Predictor of Mortality and Admission to Intensive Care Unit of COVID-19 Patients 69
[CXCR3 and CXCL10 in autoimmune thyroiditis] 64
High interleukin-6 and tumor necrosis factor-alpha serum levels in hepatitis C infection associated or not with mixed cryoglobulinemia 64
Cardiovascular risk and prostanoids in systemic sclerosis 63
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection and HCV extrahepatic manifestations 63
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature. 62
Novel Therapies for Thyroid Autoimmune Diseases 62
ADULT ONSET STILL'S DISEASE: A MULTICENTER RETROSPECTIVE COHORT STUDY OF 233 ITALIAN PATIENTS 62
From Localized Scleroderma to Systemic Sclerosis: Coexistence or Possible Evolution 62
Elevated Troponin Serum Levels in Adult Onset Still's Disease 62
Cardiac involvement in systemic sclerosis: Identification of high-risk patient profiles in different patterns of clinical presentation 62
The Morphological Domain Does Not Affect the Rate of Progression to Defined Autoimmune Diseases in Patients With Interstitial Pneumonia With Autoimmune Features 62
Aortic pulse wave velocity measurement in systemic sclerosis patients 61
Predictive Value of DLCO Reduction in Scleroderma Patients Without Cardio-Pulmonary Involvement at Baseline 61
Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis. 61
Paraneoplastic rheumatic disorders: a narrative review 61
Vascular dysfunction of COVID-19 is partially reverted in the long-term 61
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 58
Etiopathogenesis of Systemic Sclerosis: Role of Human Parvovirus B19 58
Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature 58
Scleroderma skin ulcers definition, classification and treatment strategies our experience and review of the literature 58
Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines 58
A New Method for the Assessment of Myalgia in Interstitial Lung Disease: Association with Positivity for Myositis-Specific and Myositis-Associated Antibodies 57
IP-10 in autoimmune thyroiditis 57
LONG-TERM TREATMENT WITH RITUXIMAB IN SYSTEMIC SCLEROSIS MANAGEMENT: AN OVERVIEW OF THE CLINICAL EXPERIENCE FROM A REAL-LIFE SETTING 57
Aortic root dilation in associated with the reduction in capillary density observed at nailfold capillaroscopy in SSc patients 57
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up 56
Impegno cardiaco nella sclerosi sistemica 56
Systematic review of 2008-2012 literature and update of recommendations for the use of methotrexate in rheumatic diseases, with a focus on rheumatoid arthritis 56
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 55
Micro and nanoparticles as possible pathogenetic co-factors in mixed cryoglobulinemia 55
High serum levels of silica nanoparticles in systemic sclerosis patients with occupational exposure: Possible pathogenetic role in disease phenotypes 55
Validation study of predictive value of capillaroscopic skin ulcer risk index (CSURI) in scleroderma patients treated with bosentan 55
Innovative use of magnesium oxide in the treatment of "neuralgia of the celiac plexus of rheumatic origin" by G. Moscati in 1923 55
"Usual" interstitial pneumonia with autoimmune features: a prospective study on a cohort of idiopathic pulmonary fibrosis patients 55
Assessing Humoral Immuno-Inflammatory Pathways Associated with Respiratory Failure in COVID-19 Patients 55
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 54
Reduction of carotid baroreceptor sensitivity in systemic sclerosis 54
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 54
Storia naturale della sclerosi sistemica in Italia. 54
Predictive role of capillaroscopic skin ulcer risk index in systemic sclerosis: A multicentre validation study 53
Immunomodulation of CXCL10 secretion by hepatitis C virus: Could CXCL10 be a prognostic marker of chronic hepatitis C? 53
Heart Valve Abnormalities in Systemic Sclerosis Patients: A Multicenter Cohort Study and Review of the Literature 53
High serum levels of CXCL11 in mixed cryoglobulinemia are associated with increased circulating levels of interferon-γ. 52
CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis--a longitudinal study 52
Platelet gel in the treatment of severe scleroderma skin ulcers 52
Myositis-Specific and Myositis-Associated Antibodies in Fibromyalgia Patients: A Prospective Study 51
Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers 51
HCV-related autoimmune disorders in HCV chronic infection. 51
High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C 51
The Model for Early COvid-19 Recognition (MECOR) Score: A Proof-of-Concept for a Simple and Low-Cost Tool to Recognize a Possible Viral Etiology in Community-Acquired Pneumonia Patients during COVID-19 Outbreak 51
Capillaroscopic skin ulcer risk index: A new prognostic tool for digital skin ulcer development in systemic sclerosis patients 51
The treatment of skin ulcers in systemic sclerosis: use of granulocyte-colony stimulating factor (G-CSF) in 26 patients 50
Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature 50
Endocrine Manifestations of HCV-Positive Cryoglobulinemia 50
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 50
Tocilizumab for the treatment of patients with rheumatoid arthritis and interstitial lung diseases: a case series 50
Practical suggestions on intravenous iloprost in Raynaud's phenomenon and digital ulcer secondary to systemic sclerosis: Systematic literature review and expert consensus 50
Treatment of HCV-related mixed cryoglobulinemia 50
The Impaired Elasticity of Large Arteries in Systemic Sclerosis Patients 49
Trattamento del dolore in reumatologia con oppioidi: nostra esperienza con ossicodone in pazienti con ulcere cutanee vasculitiche. 49
Osteomyelitis complicating scleroderma digital ulcers 49
Vasculiti sistemiche 49
Hepatitis C virus infection and type 2 diabetes. 49
Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin 49
Viral infections and systemic sclerosis. 48
Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia 48
Th1 and Th2 chemokine serum levels in systemic sclerosis in the presence or absence of autoimmune thyroiditis. 48
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 48
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 47
Systemic sclerosis fibroblasts show specific alterations of interferon-γ and tumor necrosis factor-α-induced modulation of interleukin 6 and chemokine ligand 2. 47
The safety of iloprost in systemic sclerosis in a real-life experience 47
Increased CXCL9 serum levels in hepatitis C-related mixed cryoglobulinemia, with autoimmune thyroiditis, associated with high levels of CXCL10. 47
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls. 47
Severe alopecia complicating systemic sclerosis 46
PERIPHERAL ARTERIAL CHANGES IN SYSTEMIC SCLEROSIS PATIENTS ARE SIMILAR TO THOSE OBSERVED IN PATIENTS WITH CORONARY ARTERY DISEASE 46
L-Arginine in pregnant scleroderma patients 46
Epstein-barr virus reactivation after infliximab in rheumatoid arthritis: a case report 46
I fattori di crescita nella rigenerazione tissutale: uso di gel piastrinico nelle ulcere cutanee associate a sclerosi sistemica. 46
Use of Neem oil and Hypericum perforatum for treatment of calcinosis-related skin ulcers in systemic sclerosis 46
Patients with mixed cryoglobulinemia and HCV infection, in presence or absence of autoimmune thyroiditis, have high serum levels of (CXC motif) ligand (CXCL)9 and CXCL11 chemokines 45
Scleroderma Digital Ulcers Complicated by Infection with Fecal Pathogens. 45
New targeted molecular therapies for dedifferentiated thyroid cancer 45
Use of 18F-fluorodeoxyglucose positron emission tomography-computed tomography in patients affected by polymyalgia rheumatica and persistent increase of acute phase reactants 44
Oxycodone in the Long-Term Treatment of Chronic Pain Related to Scleroderma Skin Ulcers 44
Totale 5.781
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.229
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.229
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021206 5 2 12 9 114 10 11 4 22 2 7 8
2021/2022816 77 126 2 6 143 12 127 31 34 9 26 223
2022/20231.838 139 80 57 182 185 329 10 265 458 18 65 50
2023/2024652 47 97 30 27 25 145 3 49 7 21 136 65
2024/20253.005 22 373 170 136 645 417 91 80 269 287 310 205
2025/2026181 181 0 0 0 0 0 0 0 0 0 0 0
Totale 7.505